CYCLOCEL

This brand name is authorized in Nigeria.

Active ingredients

The drug CYCLOCEL contains one active pharmaceutical ingredient (API):

1	Cyclophosphamide UNII 8N3DW7272P - CYCLOPHOSPHAMIDE
	Cyclophosphamide has been demonstrated to have a cytostatic effect in many tumour types. The active metabolites of cyclophosphamide are alkylating agents which transfer alkyl groups to DNA during the process of cell division, thus preventing normal synthesis of DNA.
	Read more about Cyclophosphamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4987	Powder for injection	Cyclocel-500 Injection INJ_PWD 500 mg 1 x 1's (in vial)	Powder for solution for injection in a vial	24/06/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AA01	Cyclophosphamide	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4987